Budesonide for maintenance of remission in Crohn's disease-Reference-Cited by-同舟云学术

Budesonide for maintenance of remission in Crohn's disease

Published:2014-08-21 Issue:4 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kuenzig M Ellen¹²,Rezaie Ali³,Seow Cynthia H²⁴,Otley Anthony R⁵,Steinhart A. Hillary⁶,Griffiths Anne Marie⁷,Kaplan Gilaad G²⁴,Benchimol Eric I¹

Affiliation:

1. The Children's Hospital of Eastern Ontario; Division of Gastroenterology Hepatology & Nutrition; 401 Smyth Road Ottawa ON Canada K1H 8L1

2. University of Calgary; Department of Community Health Sciences; Calgary AB Canada

3. Cedars-Sinai Medical Center; Department of Medicine; Los Angeles California USA 90048

4. University of Calgary; Department of Medicine; TRW Building Rm 6D18 3280 Hospital Drive NW Calgary AB Canada T2N 4Z6

5. IWK Health Centre; Head, Division of Gastroenterology; 5850 University Avenue Halifax NS Canada B3K 6R8

6. Mount Sinai Hospital; Department of Medicine, Division of Gastroenterology; Room 445, 600 University Avenue Toronto ON Canada M5G 1X5

7. The Hospital for Sick Children; Division of Gastroenterology, Hepatology & Nutrition; 555 University Ave. Toronto ON Canada M5G 1X8

Publisher

Wiley

Subject

Pharmacology (medical)

Reference53 articles.

1. Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease;Cortot;Gut,2001

2. Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission;Jong;Netherlands Journal of Medicine,2007

3. Low-dose budesonide treatment for prevention of postoperative recurrence of Crohn's disease: a multicentre randomized placebo-controlled trial. German Budesonide Study Group;Ewe;European Journal of Gastroenterology and Hepatology,1999

4. Oral budesonide as maintenance therapy in Crohn's disease--results of a 12-month study. Global Budesonide Study Group;Ferguson;Alimentary Pharmacology and Therapeutics,1998

5. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group;Greenberg;Gastroenterology,1996

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review: The effectiveness of 6-thioguanine nucleotide-based dose optimisation of thiopurines in the treatment of inflammatory bowel disease;Wellcome Open Research;2023-02-06

2. Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn’s Disease in Routine Clinical Practice in Turkey;Turkish Journal of Gastroenterology;2022-05-26

3. Inflammatory Bowel Disease Management during the COVID-19 Pandemic: A Literature Review;Middle East Journal of Digestive Diseases;2022-04-30

4. Current Therapy in Inflammatory Bowel Disease: Why and How We Need to Change?;EMJ Innovations;2022-01-11

5. A review of the therapeutic management of Crohn’s disease;Therapeutic Advances in Gastroenterology;2022-01